Risk Assessment of Nanoparticles

Nanotechnology is expected to be the basis of many of the main technological innovations of the 21st century. Research and development in this field is growing rapidly throughout the world. A major output of this activity is the development of new materials in the nanometre scale, including nanoparticles. These are usually defined as particulate materials with at least one dimension of less than 100 nanometres (nm). One nanometre is 10-9 m. By comparison, a human hair is approximately 70,000 nm in diameter, a red blood cell is approximately 5,000 nm wide and simple organic molecules have sizes ranging from 0.5 to 5 nm

Carbon nanotubes

Carbon nanotubes

Intracellular nanoparticles

Epithelial cell with intracellular nanoparticles

Nanoparticles include carbon nanotubes, metal nanowires, semiconductor quantum dots and other nanoparticles produced from a huge variety of substances. Responsible development of any new materials requires that risks to health and the general environment associated with the development, production, use and disposal of these materials are addressed. This is necessary to protect workers involved in production and use of these materials, the public and the ecosystem. However, it also helps inform the public debate about the development of these new, potentially beneficial, materials.

Assessment of health risks arising from exposure to chemicals or other substances, requires understanding of the intrinsic toxicity of the substance, the levels of exposure (by inhalation, by ingestion or through the skin) that may occur and any relationship between exposure and health effects. Concerns about the lack of knowledge and possible risks arising from exposure to nanoparticles led the UK Government to request advice from the Royal Society and Royal Academy of Engineering and to the formation of their Nanoscience and Nanotechnology Working Group. Their report, published in July 2004 (http://www.nanotec.org.uk), makes wide ranging recommendations about the need for more and better information and for a coherent approach to these concerns.

The IOM has unique and extensive experience concerning the potential risks from particles and fibres. Our approach combines expertise and state-of-art techniques to identify and characterise exposure scenarios, conduct toxicity evaluations and undertake risk assessments to identify, characterise and estimate the relative safety of nanoparticles. This approach allows us to extend current knowledge and facilitate comparisons between existing substances and new nanoparticles.

IOM nanoparticle activities and initiatives:

The Safety of Nano-materials Interdisciplinary Research Centre (SnIRC) Initiative

Current and recent IOM work

IOM Headquarters

Research Avenue North, Riccarton, Edinburgh, EH14 4AP | Tel: +44 (0) 131 449 8052 | Fax: 0870 850 5132

© 2008 IOM